Literature DB >> 33973174

Coronavirus: Pure Infectious Disease or Genetic Predisposition.

Farzaneh Darbeheshti1,2, Hassan Abolhassani3,4,5, Mohammad Bashashati6,7, Saeid Ghavami8,9, Sepideh Shahkarami2,10, Samaneh Zoghi4,11, Sudhir Gupta12, Jordan S Orange13, Hans D Ochs14,15, Nima Rezaei16,17,18,19.   

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes novel coronavirus disease (COVID-19), is the seventh pathogenic coronavirus recently discovered in December 2019 in Wuhan, China. To date, our knowledge about its effect on the human host remains limited. It is well known that host genetic factors account for the individual differences in the susceptibility to infectious diseases. The genetic susceptibility factors to COVID-19 and its severity are associated with several unanswered questions. However, the experience gained from an earlier strain of coronavirus, SARS-CoV-1, which shows 78% genetic similarity to SARS-CoV-2 and uses the same receptor to bind to host cells, could provide some clues. It, therefore, seems possible to assemble new evidence in order to solve a potential genetic predisposition puzzle for COVID-19. In this chapter, the puzzle pieces, including virus entry receptors, immune response, and inflammation-related genes, as well as the probable genetic predisposition models to COVID-19, are discussed.

Entities:  

Keywords:  COVID-19; Genetic predisposition; Genetic susceptibility; Polymorphism; SARS-CoV-1; SARS-CoV-2

Mesh:

Year:  2021        PMID: 33973174     DOI: 10.1007/978-3-030-63761-3_6

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  112 in total

Review 1.  New aspects on angiotensin-converting enzyme: from gene to disease.

Authors:  Bruno Baudin
Journal:  Clin Chem Lab Med       Date:  2002-03       Impact factor: 3.694

2.  Asthma and COVID-19.

Authors:  Elissa M Abrams; Geert W 't Jong; Connie L Yang
Journal:  CMAJ       Date:  2020-04-24       Impact factor: 8.262

3.  Polymorphisms in dipeptidyl peptidase IV gene are associated with the risk of myocardial infarction in patients with atherosclerosis.

Authors:  Nima Aghili; Joseph M Devaney; Lee O Alderman; Zofia Zukowska; Stephen E Epstein; Mary Susan Burnett
Journal:  Neuropeptides       Date:  2012-10-31       Impact factor: 3.286

4.  Cytokine gene polymorphisms in patients infected with hepatitis B virus.

Authors:  Ziv Ben-Ari; Eytan Mor; Orit Papo; Batia Kfir; Jaqueline Sulkes; Anat R Tambur; Ran Tur-Kaspa; Tirza Klein
Journal:  Am J Gastroenterol       Date:  2003-01       Impact factor: 10.864

5.  The heritage of pathogen pressures and ancient demography in the human innate-immunity CD209/CD209L region.

Authors:  Luis B Barreiro; Etienne Patin; Olivier Neyrolles; Howard M Cann; Brigitte Gicquel; Lluís Quintana-Murci
Journal:  Am J Hum Genet       Date:  2005-09-29       Impact factor: 11.025

6.  ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy.

Authors:  Rosanna Asselta; Elvezia Maria Paraboschi; Alberto Mantovani; Stefano Duga
Journal:  Aging (Albany NY)       Date:  2020-06-05       Impact factor: 5.682

7.  Implication of proprotein convertases in the processing and spread of severe acute respiratory syndrome coronavirus.

Authors:  Eric Bergeron; Martin J Vincent; Louise Wickham; Josée Hamelin; Ajoy Basak; Stuart T Nichol; Michel Chrétien; Nabil G Seidah
Journal:  Biochem Biophys Res Commun       Date:  2005-01-21       Impact factor: 3.575

8.  Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.

Authors:  Radwan H Ahmed; Hasniza Zaman Huri; Zaid Al-Hamodi; Sameer D Salem; Boshra Al-Absi; Sekaran Muniandy
Journal:  PLoS One       Date:  2016-04-25       Impact factor: 3.240

Review 9.  Induction and Subversion of Human Protective Immunity: Contrasting Influenza and Respiratory Syncytial Virus.

Authors:  Stephanie Ascough; Suzanna Paterson; Christopher Chiu
Journal:  Front Immunol       Date:  2018-03-02       Impact factor: 7.561

Review 10.  Managing Asthma during Coronavirus Disease-2019: An Example for Other Chronic Conditions in Children and Adolescents.

Authors:  Elissa M Abrams; Stanley J Szefler
Journal:  J Pediatr       Date:  2020-04-21       Impact factor: 4.406

View more
  1 in total

1.  Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study.

Authors:  Hamid Reza Kouhpayeh; Farhad Tabasi; Mohammad Dehvari; Mohammad Naderi; Gholamreza Bahari; Tahereh Khalili; Courtney Clark; Saeid Ghavami; Mohsen Taheri
Journal:  Transl Med Commun       Date:  2021-11-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.